Let's see if analysts think investors should be buying the dip with this quality stock. The post CSL is approaching a 5-year ...

CSL Limited (ASX:CSL) stock is about to trade ex-dividend in 2 days. The ex-dividend date is usually set to be two business ...

Its long-term returns have been outstanding. Yet eroding fundamentals and today’s prohibitive valuation imply tomorrow’s ...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical (BMRN) or CSL Limited Sponsored ADR (CSLLY). But which of these two ...

Morgan Stanley initiated coverage of CSL (CSLLY) with an Overweight rating and A$313 price target A “solid revenue growth outlook” and margin ...

Atlas Funds’ Phil Cornet says the weakness in the ASX 200 heavyweight makes no sense and Ampol is ripe for a rally.

The CSL Ltd (ASX: CSL) share price is down 1.6% to $255.51 per share, while the S&P/ASX 200 Index (ASX: XJO) is trading in ...

The government will soon launch its second edition with a budgetary corpus of Rs 40,000 crore, with a special focus on ...

There is a good chance that UK-based football supporters know Chelsea is an area of London, so CFC LDN isn’t targeted at them ...

Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement with CSL Seqirus (ASX:CSL) for the exclusive rights to commercialize NEXLETOL ® (bempedoic ...

Learn More CSL Ltd (ASX: CSL) has long been regarded as one of the highest-quality companies on the ASX, but its recent share price performance has been anything but inspiring. The global ...